Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (25568)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 28, 2017 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sinagra E, Morreale GC, Mohammadian G, Fusco G, Guarnotta V, Tomasello G, Cappello F, Rossi F, Amvrosiadis G, Raimondo D. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World J Gastroenterol 2017; 23(36): 6593-6627 [PMID: 29085207 DOI: 10.3748/wjg.v23.i36.6593] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i36/6593.htm |
| Number | Citing Articles |
| 1 |
Neha R Santucci, Miguel Saps, Miranda A van Tilburg. New advances in the treatment of paediatric functional abdominal pain disorders. The Lancet Gastroenterology & Hepatology 2020; 5(3): 316 doi: 10.1016/S2468-1253(19)30256-0
|
| 2 |
Kayle Dickson, Hajer Malitan, Christian Lehmann. Imaging of the Intestinal Microcirculation during Acute and Chronic Inflammation. Biology 2020; 9(12): 418 doi: 10.3390/biology9120418
|
| 3 |
Shiv Vardan Singh, Risha Ganguly, Kritika Jaiswal, Aditya Kumar Yadav, Ramesh Kumar, Abhay K Pandey. Molecular signalling during cross talk between gut brain axis regulation and progression of irritable bowel syndrome: A comprehensive review. World Journal of Clinical Cases 2023; 11(19): 4458-4476 doi: 10.12998/wjcc.v11.i19.4458
Abstract(337) |
Core Tip(209) |
Full Article(HTML)(2177)
|
Full Article with Cover (PDF)-6680K(34)
|
Full Article (Word)-2230K(41)
|
Audio-1200K(0)
|
Peer-Review Report-317K(27)
|
Answering Reviewers-121K(24)
|
Full Article (PDF)-6489K(226)
|
Full Article (XML)-299K(34)
|
Times Cited (2)
|
Total Visits (4506)
|
Open
|
| 4 |
Gisela Chelimsky, Pippa Simpson, Liyun Zhang, Doug Bierer, Steve Komas, Balaraman Kalyanaraman, Thomas Chelimsky, Takahiro Ushida. Impaired Mitochondrial Bioenergetics Function in Pediatric Chronic Overlapping Pain Conditions with Functional Gastrointestinal Disorders. Pain Research and Management 2021; 2021: 1 doi: 10.1155/2021/6627864
|
| 5 |
Robyn Rexwinkel, Arine M. Vlieger, Miguel Saps, Merit M. Tabbers, Marc A. Benninga. A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified. European Journal of Pediatrics 2022; 181(7): 2603 doi: 10.1007/s00431-022-04459-y
|
| 6 |
Dae Young Lee, Hee Eun Kang. Pharmacokinetics of DA-6886, A New 5-HT4 Receptor Agonist, in Rats. Pharmaceutics 2022; 14(4): 702 doi: 10.3390/pharmaceutics14040702
|
| 7 |
Emanuele Sinagra, Francesca Rossi, Dario Raimondo, Giuseppe Conoscenti, Andrea Anderloni, Valentina Guarnotta, Marcello Maida. Tenapanor for the treatment of irritable bowel syndrome with constipation. Expert Review of Clinical Pharmacology 2020; 13(5): 473 doi: 10.1080/17512433.2020.1762570
|
| 8 |
Yong Li, Tingting Yang, Qing Yao, Songsong Li, En Fang, Yankun Li, Chao Liu, Weimin Li. Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation‐induced IBS‐like rats. Neurogastroenterology & Motility 2019; 31(5) doi: 10.1111/nmo.13556
|
| 9 |
Christopher Tait, Gregory S. Sayuk. The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventions. European Journal of Internal Medicine 2021; 84: 1 doi: 10.1016/j.ejim.2020.12.023
|
| 10 |
Francesco Vito Mandarino, Emanuele Sinagra, Dario Raimondo, Silvio Danese. The Role of Microbiota in Upper and Lower Gastrointestinal Functional Disorders. Microorganisms 2023; 11(4): 980 doi: 10.3390/microorganisms11040980
|
| 11 |
Farouk Drissi, Jeremy Bregeon, Guillaume Gourcerol, Catherine Le Berre-Scoul, Michel Neunlist, Guillaume Meurette. Does a rectal biopsy with intestinal barrier permeability assessment could be a biomarker of sacral neuromodulation success in fecal incontinent patients?. Surgery Open Digestive Advance 2024; 13: 100123 doi: 10.1016/j.soda.2023.100123
|
| 12 |
Ning Zhu, Liuyan Zhu, Xueliang Zhang, Chengbin Huang, Wenjun Xiang, Bingwu Huang. Triptolide attenuates irritable bowel syndrome via inhibiting ODC1. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02847-8
|
| 13 |
M.A. Livzan, O.V. Gaus. Fecal zonulin as a biomarker of increased intestinal permeability in patients with irritable bowel syndrome (narrative review and pilot study results). Dokazatel'naya gastroenterologiya 2021; 10(3): 47 doi: 10.17116/dokgastro20211003147
|
| 14 |
György Bárdos. Irritable bowel syndrome (IBS): could we decide what is behind?. Biologia Futura 2024; doi: 10.1007/s42977-024-00205-7
|
| 15 |
Yu.M. Stepanov, I.Ya. Budzak, Yu.A. Gaidar. Morphological manifestations of irritable bowel syndrome. GASTROENTEROLOGY 2021; 55(2): 108 doi: 10.22141/2308-2097.55.2.2021.233635
|
| 16 |
M. A. Osadchuk, A. A. Svistunov, N. V. Kireeva, M. M. Osadchuk. Functional diseases of the gastrointestinal tract in the context with overlapping functional disorders: current status of the problem. Terapevticheskii arkhiv 2020; 92(2): 111 doi: 10.26442/00403660.2020.02.000458
|
| 17 |
Nils Günnewich, Thorsten Rose, Kathrin Koll, Kurt Appel. Magen-Darm-Entoxin® Shows Anti-Inflammatory Effects in vitro. Complementary Medicine Research 2021; 28(5): 473 doi: 10.1159/000514525
|
| 18 |
Laura Beatrice Mattioli, Maria Frosini, Rosa Amoroso, Cristina Maccallini, Elda Chiano, Rita Aldini, Francesco Urso, Ivan Corazza, Matteo Micucci, Roberta Budriesi. Olea europea L. Leaves and Hibiscus sabdariffa L. Petals Extracts: Herbal Mix from Cardiovascular Network Target to Gut Motility Dysfunction Application. Nutrients 2022; 14(3): 463 doi: 10.3390/nu14030463
|
| 19 |
Francesca Curci, Filomena Corbo, Maria Lisa Clodoveo, Lara Salvagno, Antonio Rosato, Ivan Corazza, Roberta Budriesi, Matteo Micucci, Laura Beatrice Mattioli. Polyphenols from Olive-Mill Wastewater and Biological Activity: Focus on Irritable Bowel Syndrome. Nutrients 2022; 14(6): 1264 doi: 10.3390/nu14061264
|
| 20 |
Emanuele Sinagra, Francesco Vito Mandarino, Marcello Maida, Daniela Cabibi, Francesca Rossi, Dario Raimondo, Guido Manfredi. Focal Active Colitis: What Are Its Clinical Implications? A Narrative Review. Biomedicines 2023; 11(10): 2631 doi: 10.3390/biomedicines11102631
|
| 21 |
Ilmaben S Vahora, Nicholas Tsouklidis, Rajat Kumar, Ravi Soni, Safeera Khan. How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome. Cureus 2020; doi: 10.7759/cureus.9871
|
| 22 |
Lijun Mei, Jiaoli Zhou, Yimo Su, Kunhong Mao, Jing Wu, Caicai Zhu, Ling He, Ying Cui. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01693-w
|
| 23 |
Xiao-Ya Li, Zhou-Jin Tan. Modern biological connotation of diarrhea with kidney-Yang deficiency syndrome. World Chinese Journal of Digestology 2022; 30(3): 119 doi: 10.11569/wcjd.v30.i3.119
|
| 24 |
Yu Zhang, Lu Zhang, Shuang Li, Xia-Xin Wu, Ya-Xin Bi, Xu Hu, Yu-Qing Chen, Yuan Yuan. Serum levels of high sensitive C-reactive protein and tumor necrosis factor-alpha in different subtypes of irritable bowel syndrome and their correlation. World Chinese Journal of Digestology 2020; 28(16): 782 doi: 10.11569/wcjd.v28.i16.782
|
| 25 |
L. B. Lazebnik, E. V. Golovanova, B. A. Volel, N. V. Korochanskaya, E. A. Lyalyukova, M. V. Mokshina, S. N. Mekhtiev, O. A. Mekhtieva, Z. V. Metsaeva, D. S. Petelin, V. I. Simanenkov, S. I. Sitkin, S. V. Cheremushkin, M. V. Chernogorova, А. I. Khavkin. Functional gastrointestinal disorders. Overlap syndrome Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine and Gastroenterological Scientific Society of Russia. Experimental and Clinical Gastroenterology 2021; (8): 5 doi: 10.31146/1682-8658-ecg-192-8-5-117
|
| 26 |
Uday C Ghoshal. Marshall and Warren Lecture 2019: A paradigm shift in pathophysiological basis of irritable bowel syndrome and its implication on treatment. Journal of Gastroenterology and Hepatology 2020; 35(5): 712 doi: 10.1111/jgh.15032
|
| 27 |
Emanuele Sinagra, Erika Utzeri, Gaetano Cristian Morreale, Carlo Fabbri, Fabio Pace, Andrea Anderloni. Microbiota-gut-brain axis and its affect inflammatory bowel disease: Pathophysiological concepts and insights for clinicians. World Journal of Clinical Cases 2020; 8(6): 1013-1025 doi: 10.12998/wjcc.v8.i6.1013
|
| 28 |
Oscar J. Cordero, Rubén Varela-Calviño, Begoña Graña-Suárez, Alba García-López. Foundations of Colorectal Cancer. 2022; : 435 doi: 10.1016/B978-0-323-90055-3.00031-4
|
| 29 |
Francesco Vito Mandarino, Emanuele Sinagra, Alberto Barchi, Maria Chiara Verga, Daniele Brinch, Dario Raimondo, Silvio Danese. Gastroparesis: The Complex Interplay with Microbiota and the Role of Exogenous Infections in the Pathogenesis of the Disease. Microorganisms 2023; 11(5): 1122 doi: 10.3390/microorganisms11051122
|
| 30 |
Yoshiharu Uno. Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel disease. Medical Hypotheses 2019; 132: 109324 doi: 10.1016/j.mehy.2019.109324
|
| 31 |
Oscar J. Cordero, Rubén Varela-Calviño, Begoña Graña-Suárez. Cancer Immunology. 2020; : 261 doi: 10.1007/978-3-030-57949-4_10
|
| 32 |
Biljana Radovanovic-Dinic, Snezana Tesic-Rajkovic, Sasa Grgov, Gordana Petrovic, Valentina Zivkovic. Irritable bowel syndrome - from etiopathogenesis to therapy. Biomedical Papers 2018; 162(1): 1 doi: 10.5507/bp.2017.057
|
| 33 |
Yu Zhang, Xia‐Xin Wu, Shuang Li, Jin‐Feng Wu, Sen Han, Zhi‐Jie Lin, Shi‐Zhen Ding, Wei‐Juan Gong. Peroxiredoxin 1 as an inflammatory marker in diarrhea‐predominant and postinfectious irritable bowel syndrome. Neurogastroenterology & Motility 2020; 32(2) doi: 10.1111/nmo.13741
|
| 34 |
Vassilia Theodorou, Catherine Beaufrand, Sophie Yvon, Guylaine Laforge, Yvonne Burmeister, Andrea Müller, Bernd Seilheimer, Lionel Bueno, Helene Eutamene. The multicomponent medication Spascupreel attenuates stress‐induced gut dysfunction in rats. Neurogastroenterology & Motility 2020; 32(5) doi: 10.1111/nmo.13798
|
| 35 |
Tingting Cai, Xiang Wang, Bangjie Li, Fei Xiong, Hao Wu, Xinghao Yang. Deciphering the synergistic network regulation of active components from SiNiSan against irritable bowel syndrome via a comprehensive strategy: Combined effects of synephrine, paeoniflorin and naringin. Phytomedicine 2021; 86: 153527 doi: 10.1016/j.phymed.2021.153527
|